Market
Entity to release significant findings from Pfizer documents by end of 2024?
2
Resolution / Starting Odds
Independent Researchers • 25%
Mainstream Media • 25%
Government Agencies • 25%
Pfizer • 25%
Major news reports or scientific publications attributing significant findings to a specific entity
Story
FDA Ordered to Release Over a Million Pages of Pfizer's Vaccine Trial Documents in Transparency Win
Dec 7, 2024, 01:39 AM
A U.S. federal judge has ordered the Food and Drug Administration (FDA) to release an additional million pages of documents related to Pfizer's COVID-19 vaccine trials. This decision follows a lawsuit filed by Aaron Siri, who has been advocating for transparency in the vaccine approval process. The FDA had previously attempted to keep these documents hidden from the public for 75 years, citing the need for time to process the extensive data. The court's ruling marks a significant victory for transparency, as it compels the FDA to disclose information underpinning its authorization of the vaccines, despite the agency's efforts to end the public records lawsuit.
View original story
Similar markets
No significant impact • 25%
Legal challenges against FDA • 25%
Increased transparency and trust • 25%
Policy changes in vaccine approval • 25%
Vaccine efficacy data • 25%
Trial participant demographics • 25%
Regulatory approval process • 25%
Adverse side effects • 25%
CDC • 25%
WHO • 25%
Pfizer • 25%
FDA • 25%
FDA • 25%
Pfizer • 25%
Public Health Organizations • 25%
No major impact on any organization • 25%
Decreased trust in vaccines • 25%
Indifference • 25%
Increased trust in vaccines • 25%
Increased demand for transparency • 25%
Increase trust • 25%
Decrease trust • 25%
Mixed impact • 25%
No significant change • 25%
